Evaluation of the Potential Clinical and Economic Effects of Bodyweight Stabilisation with Acarbose in Patients with Type 2 Diabetes Mellitus
- 1 January 1998
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 13 (4) , 449-459
- https://doi.org/10.2165/00019053-199813040-00007
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Acarbose: Its Role in the Treatment of Diabetes MellitusAnnals of Pharmacotherapy, 1996
- United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years.1995
- The Efficacy of Acarbose in the Treatment of Patients with Non–Insulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical TrialAnnals of Internal Medicine, 1994
- [Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus].1991
- The economic costs of non-insulin-dependent diabetes mellitusPublished by American Medical Association (AMA) ,1989
- Oral Hypoglycemic AgentsNew England Journal of Medicine, 1989
- Symptomatic Hypoglycemia in NIDDM Patients Treated With Oral Hypoglycemic AgentsDiabetes Care, 1989
- CENTRAL OBESITY AND CORONARY HEART DISEASE IN MENThe Lancet, 1987
- RELATIVE INCIDENCE OF SEVERE SULFONYLUREA HYPOGLYCEMIA IN THE LAST 25 YEARS IN SWITZERLAND1986
- Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up StudyDiabetes, 1974